Question 1

What is Tempest Therapeutics, Inc. (TPST)'s latest shareholders’ equity?

Accepted Answer

Tempest Therapeutics, Inc. (TPST)'s shareholders’ equity for FY2017 was -$130.7M, as reported in its SEC filings.

Question 2

How has Tempest Therapeutics, Inc. (TPST)'s shareholders’ equity changed year over year?

Accepted Answer

TPST's shareholders’ equity went from $108.2M in FY2016 to -$130.7M in FY2017, a decrease of 220.8%.

Question 3

What is the highest shareholders’ equity Tempest Therapeutics, Inc. (TPST) reported over FY2016–FY2017?

Accepted Answer

The highest reported shareholders’ equity over FY2016–FY2017 was $108.2M, in FY2016.

Question 4

What years does this shareholders’ equity history cover?

Accepted Answer

This page shows TPST's shareholders’ equity for each fiscal year from FY2016 to FY2017, drawn from SEC XBRL filings.

Fiscal year	Value	YoY
FY2017	-$130.7M	-220.8%
FY2016	$108.2M	—

Tempest Therapeutics, Inc. (TPST) Shareholders’ equity 2016–2017

More TPST financial trends